Mangoceuticals, Inc. Common Stock
MGRX
$0.48+6.97%
End of day · as of Sep 19, 2026, 3:31 PM ET
Mkt cap
$16.29M
EV/Sales
32.5
P/E ratio
N/A
FY2025 Revenue
$456,021
EPS (FY2025)
$-2.05
Gross Margin (FY2025)
54.91%
Profit Margin (FY2025)
-4526.76%
Beta
2.76
Div yield
N/A
Sector
Healthcare
Mangoceuticals, Inc. Common Stock (MGRX) is a health information services company listed on US.
Latest reported MGRX revenue for 2025-12-31 was $456.0K. Net income was -$20.6M. Revenue was down 26.0% from 2024-12-31 to 2025-12-31. MGRX currently screens at market cap $16.3M.
Use this MGRX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full MGRX income, balance, and cash tables.
Mangoceuticals, Inc. Common Stock (MGRX) is a health information services company in the Healthcare sector.
Latest cached Mangoceuticals, Inc. Common Stock (MGRX) revenue for Dec 31, 2025 was $456.0K. Net income was -$20.6M. Statements: https://lician.com/financials/mgrx
Mangoceuticals, Inc. Common Stock (MGRX) market capitalization is $16.3M on the latest cached snapshot.
Mangoceuticals, Inc. Common Stock (MGRX) cached previous close $0.45; day range $0.40 – $0.48; volume 1,590,112. Session quote: https://lician.com/quote/mgrx
Mangoceuticals, Inc. Common Stock (MGRX) latest cached earnings event is "MGRX earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached MGRX filing is 8-K · Oct 9, 2026. Filings: https://lician.com/sec/mgrx